Myocardial angiogenesis

Eiji Toyota1, Toshiro Matsunaga, William M Chilian

  • 1Department of Physiology, Louisiana State University Health Sciences Center, College of Medicine, New Orleans, LA 70112, USA.

Insights

Coronary angiogenesis and collateral growth restore blood flow to ischemic hearts. Key factors like vascular endothelial growth factor and angiopoietins are crucial for this adaptation, highlighting a balance between growth and inhibitory factors.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Physiology

Background:

  • Myocardial ischemia triggers coronary angiogenesis and collateral growth to restore blood flow.
  • The precise mechanisms, including specific factors, signaling pathways, and their temporal dynamics, remain incompletely understood.
  • A balance between pro-angiogenic and anti-angiogenic factors is critical for successful adaptation.

Purpose of the Study:

  • To review the pivotal roles of key factors in coronary angiogenesis and collateral growth.
  • To elucidate the complex interplay of signaling pathways involved in the adaptation to myocardial ischemia.
  • To highlight the importance of growth factors and inhibitors in restoring myocardial function.

Main Methods:

  • This review synthesizes current literature on coronary angiogenesis and collateral growth.
  • It focuses on the roles of vascular endothelial growth factor, angiopoietins, and angiostatin.
  • The review discusses signaling cascades and interactions among pathways.

Main Results:

  • Vascular endothelial growth factor (VEGF) is a key driver of angiogenesis.
  • Angiopoietins and angiostatin modulate vascular development and stability.
  • A coordinated action of multiple factors ensures effective adaptation to ischemia.

Conclusions:

  • Coronary adaptations to ischemia involve a complex symphony of angiogenic and angiostatic factors.
  • Vascular endothelial growth factor, angiopoietins, and angiostatin are central players in this process.
  • Maintaining a balance between growth promotion and inhibition is essential for salvaging ischemic myocardium.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...